ReviewPharmacy (Basel, Switzerland)2023
The Critical Role of Pharmacists in the Clinical Delivery of Pharmacogenetics in the U.S.
Review in Pharmacy (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed.
- Training Status and Self-Reported Training Coverage of Clinical Pharmacists Across Chinese Secondary and Tertiary Hospitals: A Cross-Sectional Survey.Healthcare (Basel, Switzerland) · 2026Article
- Pharmacogenetics in Community Pharmacy: Global Perspectives and Implementation.Journal of clinical medicine · 2026Review
- Knowledge and Attitudes Regarding Pharmacogenetics of Pharmacists in the Netherlands: A National Online Survey Study.Journal of evaluation in clinical practice · 2026Article
- International expert perspectives on pharmacogenomics in pharmacy education: a qualitative study with implications for South Africa.Frontiers in pharmacology · 2026Article
- Pharmacotherapy Risks in Rare Genetic Diseases: Cross-Referencing ACMG Secondary Findings v3.2 List With Clinical Databases.Clinical and translational science · 2026Article
- Integrating genetic insights into pain management and opioid use optimization in chronic pain and substance abuse populations.Exploratory research in clinical and social pharmacy · 2025Article
- Exploring the Clinical Workflow in Pharmacogenomics Clinics: An Observational Study.Journal of personalized medicine · 2025Article
- Enhancing Rural Healthcare Accessibility: A Model for Pharmacogenomics Adoption via an Outreach-Focused Integration Strategy.Journal of personalized medicine · 2025Article
- Clinical pharmacogenetics: A feasibility study of pharmacy students using a clinical decision support system during their didactic training.Innovations in pharmacy · 2025Article
- Pharmacogenomics in pediatric oncology: Australian adolescent or young adult and caregiver perspectives.Genetics in medicine open · 2025Article
- Article
- Understanding general practitioner and pharmacist preferences for pharmacogenetic testing in primary care: a discrete choice experiment.The pharmacogenomics journal · 2024Article
- Discussion on the optimization of personalized medication using information systems based on pharmacogenomics: an example using colorectal cancer.Frontiers in pharmacology · 2024Review
- The Potential Roles of Pharmacists in the Clinical Implementation of Pharmacogenomics.Pharmacy (Basel, Switzerland) · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Since the rebirth of pharmacogenomics (PGx) in the 1990s and 2000s, with new discoveries of genetic variation underlying adverse drug response and new analytical technologies such as sequencing and microarrays, there has been much interest in the clinical application of PGx testing. The early involvement of pharmacists in clinical studies and the establishment of organizations to support the dissemination of information about PGx variants have naturally resulted in leaders in clinical implementation. This paper presents an overview of the evolving role of pharmacists, and discusses potential challenges and future paths, primarily focused in the U.S. Pharmacists have positioned themselves as leaders in clinical PGx testing, and will prepare the next generation to utilize PGx testing in their scope of practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.